Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine

Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine (2002)

Authors:
Autor USP: MACHADO, MARCEL CERQUEIRA CESAR - FM
Unidade: FM
Subjects: NEOPLASIAS PANCREÁTICAS (QUIMIOTERAPIA); ESTADIAMENTO DE NEOPLASIAS; PROGNÓSTICO
Language: Inglês
Imprenta:
- Publisher place: Totowa, NJ
- Date published: 2002
Source:
- Título do periódico: International Journal of Gastrointestinal Cancer
- ISSN: 1537-3649
- Volume/Número/Paginação/Ano: v. 32, n. 1, p. 35-41, 2002

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

ABNT

SAAD, Everardo D. et al. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer, v. 32, n. 1, p. 35-41, 2002Tradução . . Acesso em: 21 maio 2024.
APA

Saad, E. D., Machado, M. C., Wajsbrot, D., Abramoff, R., Hoff, P. M., Tabacof, J., et al. (2002). Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer, 32( 1), 35-41.
NLM

Saad ED, Machado MC, Wajsbrot D, Abramoff R, Hoff PM, Tabacof J, Katz A, Simon SD, Gansl RC. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer. 2002 ; 32( 1): 35-41.[citado 2024 maio 21 ]
Vancouver

Saad ED, Machado MC, Wajsbrot D, Abramoff R, Hoff PM, Tabacof J, Katz A, Simon SD, Gansl RC. Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine. International Journal of Gastrointestinal Cancer. 2002 ; 32( 1): 35-41.[citado 2024 maio 21 ]